Plain-English translation of NCT07229170 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers want to understand how semaglutide and tirzepatide — medications that help with weight loss — affect the way food tastes and how people eat. This study will look at medical records from patients in Italy who have already taken these medications for at least 12 weeks, to see what changes they experienced in their taste, food preferences, and eating behavior.
Doctors have noticed that people taking this medication often describe changes in how food tastes and what they want to eat, but there hasn't been much research documenting exactly what these changes are and how common they are. This study aims to better understand these side effects so doctors can help patients prepare for and manage them.
You likely qualify if…
You likely don't qualify if…
This is a retrospective study, meaning researchers will review your existing medical records and data — you won't need to take any new medication or undergo any new procedures. Researchers will collect information from your clinic visits, dietary questionnaires, and body composition measurements that were already done as part of your regular care over at least 12 weeks of treatment. There are no additional appointments or costs for you.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
Italy